🏥
/https://tf-cmsv2-smithsonianmag-media.s3.amazonaws.com/filer_public/c1/a2/c1a2a82f-5e62-4728-a670-4816f111957b/beta-amyloid_plaques_and_tau_in_the_brain_38686503251.png)
🏥 Health
Experimental Tau-Targeting Alzheimer's Drug Slows Cognitive Decline in Trial
A new clinical trial shows that an experimental drug targeting tangles of the protein tau — a notoriously difficult therapeutic target — can slow cognitive decline in Alzheimer's patients at rates comparable to FDA-approved amyloid-clearing treatments. The findings suggest tau is a viable alternative target for future therapies. Researchers say the results open a new avenue in Alzheimer's treatment.
Comments
No comments yet
Comments
No comments yet — be the first to weigh in 👇
No comments yet. Be the first!